Home Cart Sign in  
Chemical Structure| 620175-39-5 Chemical Structure| 620175-39-5

Structure of AFN-1252
CAS No.: 620175-39-5

Chemical Structure| 620175-39-5

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

AFN-1252 is a FabI (staphylococcal enoyl-acyl carrier protein reductase) inhibitor with Ki value of 12.8 nM, used as a potent antibiotic against Staphylococcus aureus.

Synonyms: API-1252; Debio 1452

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of AFN-1252

CAS No. :620175-39-5
Formula : C22H21N3O3
M.W : 375.42
SMILES Code : O=C(N(C)CC1=C(C)C2=CC=CC=C2O1)/C=C/C3=CC(CC4)=C(N=C3)NC4=O
Synonyms :
API-1252; Debio 1452
MDL No. :MFCD18633190
InChI Key :QXTWSUQCXCWEHF-JXMROGBWSA-N
Pubchem ID :10407120

Safety of AFN-1252

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
Staphylococcus aureus USA300 FPR3757 0.5 μg/ml 17 h Evaluate the effect of AFN-1252 on the growth of S. aureus, showing that AFN-1252 significantly slowed bacterial growth and increased the proportion of C18:2 in the membrane. J Lipid Res. 2024 Dec;65(12):100693
Escherichia coli (ATCC 35218) 0.5 µg/mL 20 h When used alone, AFN-1252 allowed S. aureus to adapt and resume exponential growth after a 10-hour latency period. However, when AFN-1252 was combined with mushroom extracts, particularly the acetonic extract of white A. bisporus (AW), it significantly extended the anti-FASII latency period and completely inhibited bacterial growth Foods. 2024 May 30;13(11):1715
Clinical MRSA isolates 0.15 μg/ml 8 h To test whether AFN-1252 could block daptomycin-induced phospholipid release in clinical isolates. Results showed that the presence of AFN-1252 prevented daptomycin inactivation, correlating with a significant reduction in the survival of daptomycin-inactivating bacterial isolates. Antimicrob Agents Chemother. 2019 Mar 27;63(4):e02105-18
Burkholderia pseudomallei R15 strain 2.35 mg/L Evaluated the antibacterial activity of AFN-1252 against Burkholderia pseudomallei R15 strain, showing an MIC of 2.35 mg/L. Protein Sci. 2015 May;24(5):832-40
Streptococcus pneumoniae >4 μg/ml 20-24 h To evaluate the in vitro activity of AFN-1252 against Streptococcus pneumoniae, showing no activity (MIC90>4 μg/ml) Antimicrob Agents Chemother. 2009 Aug;53(8):3544-8
Staphylococcus epidermidis <0.12 μg/ml 20-24 h To evaluate the in vitro activity of AFN-1252 against Staphylococcus epidermidis, showing MICs ≤0.12 μg/ml for all tested strains (including methicillin-resistant strains) Antimicrob Agents Chemother. 2009 Aug;53(8):3544-8
Staphylococcus aureus <0.12 μg/ml 20-24 h To evaluate the in vitro activity of AFN-1252 against Staphylococcus aureus, showing MICs ≤0.12 μg/ml for all tested strains (including methicillin-resistant strains) Antimicrob Agents Chemother. 2009 Aug;53(8):3544-8
Staphylococcus aureus ATCC 43300 0.008 μg/ml 24 h Evaluate the bactericidal activity of AFN-1252 against MRSA, showing a >2-log10 reduction in bacterial counts over 24 hours Antimicrob Agents Chemother. 2012 Nov;56(11):5865-74
Staphylococcus aureus ATCC 29213 0.008 μg/ml 24 h Evaluate the bactericidal activity of AFN-1252 against S.aureus, showing a >2-log10 reduction in bacterial counts over 24 hours Antimicrob Agents Chemother. 2012 Nov;56(11):5865-74
Staphylococcus aureus Wood46 50 ng/ml 15 min To study the effect of AFN-1252 on virulence gene expression at different growth stages, results showed that AFN-1252 significantly suppressed virulence gene expression in log-phase cells, but had minimal effect in slower-growing cells. Antimicrob Agents Chemother. 2013 May;57(5):2182-90
Staphylococcus aureus RN4220 50 ng/ml 15 min To investigate the effect of AFN-1252 on gene expression in S. aureus, results showed that AFN-1252 significantly increased the expression of fatty acid synthetic genes and repressed the expression of virulence genes controlled by the SaeRS 2-component regulator in exponentially growing cells. Antimicrob Agents Chemother. 2013 May;57(5):2182-90
Staphylococcus aureus strain RN4220 40 ng/ml 48 h Screen for AFN-1252-resistant mutants, identified FabI(M99T) and FabI(Y147H) mutations J Biol Chem. 2013 Dec 20;288(51):36261-71
Neisseria gonorrhoeae 4 μM 45 min AFN-1252 selectively inhibited lipid biosynthesis by 75%, with less than 5% inhibition of protein, DNA, or RNA biosynthetic pathways J Biol Chem. 2016 Jan 1;291(1):171-81
Neisseria gonorrhoeae 1, 2, 4, 8, 16 μM 45 min AFN-1252 caused a dose-dependent inhibition of fatty acid synthesis, with greater than 95% inhibition achieved at 16 μM AFN-1252 J Biol Chem. 2016 Jan 1;291(1):171-81

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Mouse Septicemia model Oral 1 mg/kg Single dose Evaluate the efficacy of AFN-1252 in a mouse septicemia model, showing 100% protection with a single oral dose of 1 mg/kg Antimicrob Agents Chemother. 2012 Nov;56(11):5865-74
CD-1 mice Subcutaneous granuloma infection model Oral 100 mg/kg Single or three doses, 24 hours apart To evaluate the efficacy and pharmacokinetic parameters of AFN-1252 in a mouse granuloma infection model, results showed that AFN-1252 reached therapeutic levels at the infection site and significantly reduced bacterial load. Antimicrob Agents Chemother. 2013 May;57(5):2182-90

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.66mL

0.53mL

0.27mL

13.32mL

2.66mL

1.33mL

26.64mL

5.33mL

2.66mL

References

 

Historical Records

Categories